These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 25434825)

  • 1. A simulation model to estimate cost-offsets for a disease-management program for chronic kidney disease.
    Gandjour A; Tschulena U; Steppan S; Gatti E
    Expert Rev Pharmacoecon Outcomes Res; 2015 Apr; 15(2):341-7. PubMed ID: 25434825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effective treatment modalities for reducing morbidity associated with chronic kidney disease.
    Ferguson TW; Tangri N; Rigatto C; Komenda P
    Expert Rev Pharmacoecon Outcomes Res; 2015 Apr; 15(2):243-52. PubMed ID: 25661187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-utility analysis of the National Health Screening Program for chronic kidney disease in Korea.
    Go DS; Kim SH; Park J; Ryu DR; Lee HJ; Jo MW
    Nephrology (Carlton); 2019 Jan; 24(1):56-64. PubMed ID: 29206319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic Modelling of Chronic Kidney Disease: A Systematic Literature Review to Inform Conceptual Model Design.
    Sugrue DM; Ward T; Rai S; McEwan P; van Haalen HGM
    Pharmacoeconomics; 2019 Dec; 37(12):1451-1468. PubMed ID: 31571136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A policy model of cardiovascular disease in moderate-to-advanced chronic kidney disease.
    Schlackow I; Kent S; Herrington W; Emberson J; Haynes R; Reith C; Wanner C; Fellström B; Gray A; Landray MJ; Baigent C; Mihaylova B;
    Heart; 2017 Dec; 103(23):1880-1890. PubMed ID: 28780579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?
    Kent S; Schlackow I; Lozano-Kühne J; Reith C; Emberson J; Haynes R; Gray A; Cass A; Baigent C; Landray MJ; Herrington W; Mihaylova B;
    BMC Nephrol; 2015 Apr; 16():65. PubMed ID: 25924679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-analysis of persistent hyperkalaemia in non-dialysis chronic kidney disease patients under nephrology care in Italy.
    Provenzano M; De Francesco M; Iannazzo S; Garofalo C; Andreucci M; Genualdo R; Borrelli S; Minutolo R; Conte G; De Nicola L
    Int J Clin Pract; 2020 May; 74(5):e13475. PubMed ID: 31909866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced chronic kidney disease, end-stage renal disease and renal death among HIV-positive individuals in Europe.
    Ryom L; Kirk O; Lundgren JD; Reiss P; Pedersen C; De Wit S; Buzunova S; Gasiorowski J; Gatell JM; Mocroft A;
    HIV Med; 2013 Sep; 14(8):503-8. PubMed ID: 23590641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of hepatitis B vaccination using HEPLISAV™ in selected adult populations compared to Engerix-B® vaccine.
    Kuan RK; Janssen R; Heyward W; Bennett S; Nordyke R
    Vaccine; 2013 Aug; 31(37):4024-32. PubMed ID: 23707166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic kidney disease progression to end stage renal disease: a single center experience of the role of the underlying kidney disease.
    Ekart R; Ferjuc A; Furman B; Gerjevič Š; Bevc S; Hojs R
    Ther Apher Dial; 2013 Aug; 17(4):363-7. PubMed ID: 23931872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epidemiology of chronic kidney disease].
    Noël D; Landais P
    Rev Prat; 2012 Jan; 62(1):38-42. PubMed ID: 22335065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. All-cause costs increase exponentially with increased chronic kidney disease stage.
    Golestaneh L; Alvarez PJ; Reaven NL; Funk SE; McGaughey KJ; Romero A; Brenner MS; Onuigbo M
    Am J Manag Care; 2017 Jun; 23(10 Suppl):S163-S172. PubMed ID: 28978205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease.
    Perkins RM; Kirchner HL; Hartle JE; Bucaloiu ID
    Clin Nephrol; 2013 Oct; 80(4):256-62. PubMed ID: 23993165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of stage 1-5 chronic kidney disease in Mainland China.
    Lai X; Zhang AH; Chen SY; He L; Su CY; Fan MH; Wang T
    Ren Fail; 2014 May; 36(4):520-5. PubMed ID: 24456114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidisciplinary care program for advanced chronic kidney disease: reduces renal replacement and medical costs.
    Chen PM; Lai TS; Chen PY; Lai CF; Yang SY; Wu V; Chiang CK; Kao TW; Huang JW; Chiang WC; Lin SL; Hung KY; Chen YM; Chu TS; Wu MS; Wu KD; Tsai TJ
    Am J Med; 2015 Jan; 128(1):68-76. PubMed ID: 25149427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health benefits and costs of screening for colorectal cancer in people on dialysis or who have received a kidney transplant.
    Wong G; Li MW; Howard K; Hua DK; Chapman JR; Bourke M; Turner R; Tong A; Craig JC
    Nephrol Dial Transplant; 2013 Apr; 28(4):917-26. PubMed ID: 23182812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
    Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of medical therapy in patients with chronic kidney disease and end-stage renal disease.
    Weir MR; Fink JC
    Curr Opin Nephrol Hypertens; 2014 May; 23(3):306-13. PubMed ID: 24670404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of multidisciplinary care for chronic kidney disease in Taiwan: a 3-year prospective cohort study.
    Chen YR; Yang Y; Wang SC; Chiu PF; Chou WY; Lin CY; Chang JM; Chen TW; Ferng SH; Lin CL
    Nephrol Dial Transplant; 2013 Mar; 28(3):671-82. PubMed ID: 23223224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From CKD to ESRD: a tale of two transitions.
    Kossmann RJ
    Adv Chronic Kidney Dis; 2011 Nov; 18(6):439-42. PubMed ID: 22098663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.